134 related articles for article (PubMed ID: 36927659)
1. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
Chang D; Liu XX; Liu R; Sun JW
Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
[TBL] [Abstract][Full Text] [Related]
2. Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes.
Sun Q; Liu R; Zhang H; Zong L; Jing X; Ma L; Li J; Zhang L
PeerJ; 2023; 11():e16526. PubMed ID: 38077434
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
Zhang Y; Yang X; Wu H; Zhou W; Liu Z
Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
[TBL] [Abstract][Full Text] [Related]
4. EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Wang CQ; Li Y; Huang BF; Zhao YM; Yuan H; Guo D; Su CM; Hu GN; Wang Q; Long T; Wang Y; Tang CH; Li X
Sci Rep; 2017 Nov; 7(1):15654. PubMed ID: 29142206
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
[TBL] [Abstract][Full Text] [Related]
6. LYAR Promotes Colorectal Cancer Progression by Upregulating
Wu Y; Zhou Y; Gao H; Wang Y; Cheng Q; Jian S; Ding Q; Gu W; Yao Y; Ma J; Wu W; Li Y; Tong X; Song X; Ma S
Oxid Med Cell Longev; 2021; 2021():9979707. PubMed ID: 35069968
[TBL] [Abstract][Full Text] [Related]
7. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
Lai C; Chen Z; Li R
Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
[TBL] [Abstract][Full Text] [Related]
9. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
[TBL] [Abstract][Full Text] [Related]
10. SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.
Li Z; Tao Y; Gao Z; Peng S; Lai Y; Li K; Chen X; Huang H
J Transl Med; 2023 May; 21(1):303. PubMed ID: 37147713
[TBL] [Abstract][Full Text] [Related]
11. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells.
Liu H; Cui J; Zhang Y; Niu M; Xue X; Yin H; Tang Y; Dai L; Dai F; Guo Y; Wu Y; Gao W
IUBMB Life; 2019 Nov; 71(11):1771-1784. PubMed ID: 31298480
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression.
Barnawi R; Al-Khaldi S; Majid S; Qattan A; Bakheet T; Fallatah M; Ghebeh H; Alajez NM; Al-Alwan M
Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959629
[TBL] [Abstract][Full Text] [Related]
16. Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.
Mahdiannasser M; Haghpanah V; Damavandi E; Kabuli M; Tavangar SM; Larijani B; Ghadami M
Mol Biol Rep; 2020 Mar; 47(3):2161-2169. PubMed ID: 32072403
[TBL] [Abstract][Full Text] [Related]
17. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?
Liu H; Zhang Y; Li L; Cao J; Guo Y; Wu Y; Gao W
Mol Ther Oncolytics; 2021 Mar; 20():240-264. PubMed ID: 33614909
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas.
Wu Y; Yuan MH; Wu HT; Chen WJ; Zhang ML; Ye QQ; Liu J; Zhang GJ
Cell Death Dis; 2020 Oct; 11(10):912. PubMed ID: 33099573
[TBL] [Abstract][Full Text] [Related]
19. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
[TBL] [Abstract][Full Text] [Related]
20. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion.
Chen JJ; Cai WY; Liu XW; Luo QC; Chen G; Huang WF; Li N; Cai JC
PLoS One; 2015; 10(5):e0126890. PubMed ID: 26010149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
